Strollo et al. reported antibodies specific to oxidatively post-translationally modified insulin (oxPTM-INS, insulin modified by hydroxyl radical) as a novel biomarker for improved prediction of T1D in children with positive standard islet autoantibodies [21]. This evidence concerns the gene INS and type 1 diabetes mellitus.